In a new agreement, giant pharmaceutical multinationals GlaxoSmithKline Plc and Pfizer Inc., the two leading developers of AIDS drugs, set up a joint company to develop drugs against HIV. This new company will hold nearly a fifth of the market for treatments against the virus. Glaxo will initially have an 85 percent stake in the [...]